Department of Kinesiology, Iowa State University, Ames, IA, USA; Program of Immunobiology, Iowa State University, Ames, IA, USA.
Nanovaccine Institute, Iowa State University, Ames, IA, USA.
Brain Behav Immun. 2022 May;102:1-10. doi: 10.1016/j.bbi.2022.02.005. Epub 2022 Feb 5.
Vaccination is an effective public health measure, yet vaccine efficacy varies across different populations. Adjuvants improve vaccine efficacy but often increase reactogenicity. An unconventional behavioral "adjuvant" is physical exercise at the time of vaccination. Here, in separate experiments, we examined the effect of 90-minute light- to moderate-intensity cycle ergometer or outdoor walk/jog aerobic exercise performed once after immunization on serum antibody response to three different vaccines (2009 pandemic influenza H1N1, seasonal influenza, and COVID-19). Exercise took place after influenza vaccination or after the first dose of Pfizer-BioNTech COVID-19 vaccine. A mouse model of influenza A immunization was used to examine the effect of exercise on antibody response and the role of IFNα as a potential mechanism by treating mice with anti-IFNα antibody. The results show that 90 min of exercise consistently increased serum antibody to each vaccine four weeks post-immunization, and IFNα may partially contribute to the exercise-related benefit. Exercise did not increase side effects after the COVID-19 vaccination. These findings suggest that adults who exercise regularly may increase antibody response to influenza or COVID-19 vaccine by performing a single session of light- to moderate-intensity exercise post-immunization.
接种疫苗是一种有效的公共卫生措施,但疫苗的效果在不同人群中有所不同。佐剂可以提高疫苗的效果,但往往会增加不良反应。一种非传统的行为“佐剂”是在接种疫苗时进行体育锻炼。在这里,我们在单独的实验中研究了接种疫苗后进行 90 分钟的低强度到中等强度的自行车或户外散步/慢跑有氧运动对三种不同疫苗(2009 年大流行性流感 H1N1、季节性流感和 COVID-19)血清抗体反应的影响。运动是在流感疫苗接种后或辉瑞-生物技术公司 COVID-19 疫苗第一剂后进行的。我们使用流感 A 免疫的小鼠模型来研究运动对抗体反应的影响,以及 IFNα 作为一种潜在机制的作用,通过用抗 IFNα 抗体治疗小鼠。结果表明,90 分钟的运动一致地增加了四种疫苗在免疫后四周的血清抗体,IFNα 可能部分有助于运动相关的益处。运动并没有增加 COVID-19 疫苗接种后的副作用。这些发现表明,经常锻炼的成年人可以通过在接种疫苗后进行一次低强度到中等强度的运动,来增加对流感或 COVID-19 疫苗的抗体反应。